Heartflow (HTFL) closed at $59.92 on November 12, 2026, up 1.4% from the previous close, on volume of 3,862,544 shares (30-day average 1,583,395).
Data as of November 12, 2026.
| # | Date | Strategy | Legs | Contracts |
|---|---|---|---|---|
| 1 | Nov 12, 2026 | Seagull With Put Spread | 20-Nov-2650 P : 55 P : 75 C | 3,312 |
| 2-3 | The next 2 largest trades are for Premium members. Start a 7-day free trial | |||
Ranked by contracts: multi-leg trades of 200 or more contracts on one day, through Nov 12, 2026. See the 10 largest for 30, 60 and 90 days
HeartFlow, Inc. (HTFL) Gets a Buy from Piper Sandler
TipRanks (Fri, 13-Nov 9:07 AM ET)
HeartFlow, Inc. Non-GAAP EPS of -$0.03 beats by $0.07, revenue of $72.86M beats by $7.66M
Seeking Alpha News (Thu, 12-Nov 4:05 PM ET)
Heartflow Reports Third Quarter 2026 Financial Results and Raises Full Year 2026 Guidance
Globe Newswire (Thu, 12-Nov 4:01 PM ET)
Here are the major earnings after the close Thursday
Seeking Alpha News (Thu, 12-Nov 10:00 AM ET)
HeartFlow Q3 2026 Earnings Preview
Seeking Alpha News (Wed, 11-Nov 5:35 PM ET)
Globe Newswire (Mon, 2-Nov 8:00 AM ET)
Globe Newswire (Sun, 1-Nov 1:45 PM ET)
Boston Scientific announces results for third quarter 2026
PRNewswire (Wed, 28-Oct 6:31 AM ET)
Market Chameleon (Tue, 20-Oct 7:57 AM ET)
Heartflow to Report Third Quarter 2026 Financial Results on November 12, 2026
Globe Newswire (Mon, 19-Oct 4:01 PM ET)
HeartFlow Inc is a commercial-stage medical technology company that provides software and artificial intelligence (AI) designed to deliver a non-invasive solution for diagnosing and managing coronary artery disease. The company operates and manages its business as a single reportable operating segment: non-invasive coronary artery disease detection solutions. Geographically, it operates in the United States and the rest of Europe, deriving the majority of its revenue from the United States. The company has developed three software products: Heartflow Roadmap Analysis, Heartflow FFRCT Analysis, and Heartflow Plaque Analysis.
Heartflow trades on the NASDAQ stock market under the symbol HTFL.
As of November 13, 2026, HTFL stock price declined to $49.05 with 2,374,781 million shares trading.
HTFL has a beta of 1.71, meaning it tends to be more sensitive to market movements. HTFL has a correlation of 0.05 to the broad based SPY ETF.
HTFL has a market cap of $4.27 billion. This is considered a Mid Cap stock.
Last quarter Heartflow reported $73 million in Revenue and -$.03 earnings per share. This beat revenue expectation by $8 million and exceeded earnings estimates by $.09.
The top ETF exchange traded funds that HTFL belongs to (by Net Assets): VTI, IWM, VB, VBR, IWO.
HTFL has outperformed the market in the last year with a return of +37.2%, while the SPY ETF gained +11.4%. In the last 3 month period, HTFL beat the market returning +64.3%, while SPY returned -2.2%. However, in the most recent 2 weeks HTFL has underperformed the stock market by returning -19.0%, while SPY returned -2.0%.
HTFL support price is $57.16 and resistance is $62.68 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that HTFL shares will trade within this expected range on the day.